Related Experiment Video

Updated: Apr 20, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.3K

Sleep, executive functioning and behaviour in children and adolescents with type 1 diabetes

Nicole C Caruso1, Branka Radovanovic1, J Declan Kennedy2

  • 1School of Psychology, Social Work and Social Policy, University of South Australia, St Bernards Road, Adelaide, 5000, SA, Australia.

Sleep Medicine
|December 3, 2014
PubMed

Insights

Children with type 1 diabetes (T1D) experience sleep problems, leading to neurocognitive and behavioral deficits. Sleep quality fully mediates these issues, highlighting the importance of good glycemic control for daytime functioning.

Area of Science:

  • Pediatric Endocrinology
  • Neuropsychology
  • Sleep Medicine

Background:

  • Type 1 diabetes (T1D) can impact children's daily functioning.
  • Previous research suggests potential links between T1D, sleep, and cognitive/behavioral issues.

Purpose of the Study:

  • To compare sleep, neurocognitive, and behavioral functioning in children with T1D versus healthy controls.
  • To investigate if sleep quality mediates the relationship between T1D and deficits in these areas.

Main Methods:

  • Study included 49 children/adolescents with T1D and 36 healthy controls (ages 6-16).
  • Parent-reported data collected via surveys on sleep, executive functions, and behavior.
  • Diabetic and demographic data obtained from medical records.

Main Results:

  • Children with T1D reported more sleep problems than controls.
  • Mild deficits in executive and behavioral functioning were observed in the T1D group.
  • Sleep quality fully mediated metacognitive, externalized, and internalized behaviors, but not behavioral regulation.

Conclusions:

  • Sleep disruption, stemming from T1D, largely explains neurocognitive and behavioral deficits in affected children.
  • Good nocturnal glycemic control is crucial for regulating daytime functioning in children with T1D.
Abstract

Keywords:
Behaviour problemsChildrenExecutive functioningMediational analysisSleepType 1 diabetes

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

7.2K
Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing10:32

Hippocampal Insulin Microinjection and In vivo Microdialysis During Spatial Memory Testing

Published on: January 11, 2013

17.2K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.5K
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
9
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
3
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K